Legend Biotech Earnings Estimates, EPS & Revenue | NASDAQ:LEGN

Comments

Legend Biotech Corp Earnings Estimates

LEGNNASDAQ

Trade with Public

$18.92

-0.05-0.26%

Last update: Mar 9, 11:01 AM

Earnings: Q4 2025 earnings tomorrow on Tue Mar 10th before the market open

Conference Call: Conference call scheduled tomorrow at 8:00 AM

Click to view the webcast

Overview NewsEarningsOptions Analyst Ratings Short Interest Stock Report

Legend Biotech Earnings Estimates, EPS & Revenue | NASDAQ:LEGN

Legend Biotech (LEGN) is scheduled to report Q4 earnings on March 10, 2026. Analysts estimate EPS of $-0.18 and quarterly revenue of $306.03M.

In the most recent quarter (Q3), Legend Biotech reported EPS of $-0.05, beating estimates of $-0.12 by 0.58%. Revenue came in at $272.33M, missing the estimate of $276.00M by 0.01%.

Over the last 4 quarters, Legend Biotech has averaged an EPS surprise of 0.62% and a revenue surprise of 0.05%.

Earnings Date

Mar 10

EPS Estimate

$-0.180

Quarterly Revenue Estimate

$306.03M

Annual Revenue
(as of Sep 30)

$909.04M

Legend Biotech Earnings History

Analyze the earnings history of Legend Biotech using advanced sorting and filters.

Legend Biotech (LEGN) Earnings Per Share

The chart below shows Legend Biotech's reported EPS compared to analyst estimates over recent quarters.

Legend Biotech (LEGN) Revenue

The chart below shows Legend Biotech's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Legend Biotech (NASDAQ:LEGN) reporting earnings?

Legend Biotech (LEGN) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.

What were the latest earnings per share (EPS) for Legend Biotech (NASDAQ:LEGN)?

The Actual EPS was $-0.05, which beat the estimate of $-0.12.

What were Legend Biotech’s (NASDAQ:LEGN) revenues?

The Actual Revenue was $272.33M, which missed the estimate of $276.00M.

People Also Watch

IDEAYA Biosciences Inc

NASDAQ:IDYA

$34.73

4.64%

Twist Bioscience Corp

NASDAQ:TWST

$44.85

-4.45%

Centessa Pharmaceuticals PLC

NASDAQ:CNTA

$25.63

-1.25%

Arcutis Biotherapeutics Inc

Xenon Pharmaceuticals Inc

Legend Biotech Earnings Estimates, EPS & Revenue | NASDAQ:LEGN

Legend Biotech (LEGN) is scheduled to report Q4 earnings on March 10, 2026. Analysts estimate EPS of $-0.18 and quarterly revenue of $306.03M.

In the most recent quarter (Q3), Legend Biotech reported EPS of $-0.05, beating estimates of $-0.12 by 0.58%. Revenue came in at $272.33M, missing the estimate of $276.00M by 0.01%.

Over the last 4 quarters, Legend Biotech has averaged an EPS surprise of 0.62% and a revenue surprise of 0.05%.

Earnings Date

Mar 10

EPS Estimate

$-0.180

Quarterly Revenue Estimate

$306.03M

Annual Revenue
(as of Sep 30)

$909.04M